within Pharmacolibrary.Drugs.ATC.V;

model V03AB26
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.9,
    Cl             = 0.5,
    adminDuration  = 600,
    adminMass      = 2.5,
    adminCount     = 1,
    Vd             = 0.00041999999999999996,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0045000000000000005,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Methionine is an essential amino acid used as a nutritional supplement and an antidote for acetaminophen poisoning. It is involved in the synthesis of proteins and other important molecules and acts as a methyl group donor in various biochemical processes. The drug is approved for clinical use primarily as a nutritional supplement and as a protective agent in cases of acetaminophen toxicity.</p><h4>Pharmacokinetics</h4><p>Estimated pharmacokinetic parameters for healthy adults, based on known amino acid pharmacokinetics and published indirect references; explicit PK data for methionine as a drug are not found in primary literature.</p><h4>References</h4><ol><li><p>Forrest, JA, et al., &amp; Prescott, LF (1982). Clinical pharmacokinetics of paracetamol. <i>Clinical pharmacokinetics</i> 7(2) 93–107. DOI:<a href=&quot;https://doi.org/10.2165/00003088-198207020-00001&quot;>10.2165/00003088-198207020-00001</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/7039926/&quot;>https://pubmed.ncbi.nlm.nih.gov/7039926</a></p></li><li><p>Chiew, AL, et al., &amp; Buckley, NA (2018). Interventions for paracetamol (acetaminophen) overdose. <i>The Cochrane database of systematic reviews</i> 2(2) CD003328–None. DOI:<a href=&quot;https://doi.org/10.1002/14651858.CD003328.pub3&quot;>10.1002/14651858.CD003328.pub3</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/29473717/&quot;>https://pubmed.ncbi.nlm.nih.gov/29473717</a></p></li><li><p>Amasya, G, et al., &amp; Yuksel, N (2021). A study to enhance the oral bioavailability of s-adenosyl-l-methionine (SAMe): SLN and SLN nanocomposite particles. <i>Chemistry and physics of lipids</i> 237 105086–None. DOI:<a href=&quot;https://doi.org/10.1016/j.chemphyslip.2021.105086&quot;>10.1016/j.chemphyslip.2021.105086</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/33930379/&quot;>https://pubmed.ncbi.nlm.nih.gov/33930379</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end V03AB26;
